The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 4, 2011, Pages

  Nicholson, Grant C ^a   Kariyawasam, Harsha H ^a   Tan, Andrew J ^a   Hohlfeld, Jens M ^b   Quinn, Deborah ^c   Walker, Christoph ^c   Rodman, David ^c   Westwick, John ^c   Jurcevic, Stipo ^d   Kon, Onn Min ^a   Barnes, Peter J ^a   Krug, Norbert ^b   Hansel, Trevor T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^c Horsham Research Centre   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allergic rhinitis; anti IL 13; mAb; nasal allergen challenge

Indexed keywords

ALLERGEN; EOTAXIN; FLUTICASONE PROPIONATE; INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; MALE; NASAL ALLERGEN CHALLENGE; NOSE MUCOSA; PHLEUM PRATENSE; PRIORITY JOURNAL; PROVOCATION TEST; SINGLE DRUG DOSE;

EID: 80053568990     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.05.013     Document Type: Article

References (27)

1. C.M. Lloyd, and E.M. Hessel Functions of T cells in asthma: more than just T(H)2 cells Nat Rev Immunol 10 2010 838 848
2. P.J. Barnes New therapies for asthma: is there any progress? Trends Pharmacol Sci 31 2010 335 343
3. B.S. Bochner, and G.J. Gleich What targeting eosinophils has taught us about their role in diseases J Allergy Clin Immunol 126 2010 16 25
4. M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, and C.L. Karp Interleukin-13: central mediator of allergic asthma Science 282 1998 2258 2260
5. G. Grünig, M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, and D.M. Rennick Requirement for IL-13 independently of IL-4 in experimental asthma Science 282 1998 2261 2263 (Pubitemid 29004075)
6. E.Y. Kim, J.T. Battaile, A.C. Patel, Y. You, E. Agapov, and M.H. Grayson Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease Nat Med 14 2008 633 640 (Pubitemid 351809546)
7. S. Miyahara, N. Miyahara, S. Matsubara, K. Takeda, T. Koya, and E.W. Gelfand IL-13 is essential to the late-phase response in allergic rhinitis J Allergy Clin Immunol 118 2006 1110 1116 (Pubitemid 44666972)
8. S.L. LaPorte, Z.S. Juo, J. Vaclavikova, L.A. Colf, X. Qi, and N.M. Heller Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system Cell 132 2008 259 272 (Pubitemid 351172435)
9. L.C. Borish, H.S. Nelson, M.J. Lanz, L. Claussen, J.B. Whitmore, and J.M. Agosti Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo-controlled trial Am J Respir Crit Care Med 160 1999 1816 1823 (Pubitemid 30004681)
10. L.C. Borish, H.S. Nelson, J. Corren, G. Bensch, W.W. Busse, and J.B. Whitmore Efficacy of soluble IL-4 receptor for the treatment of adults with asthma J Allergy Clin Immunol 107 2001 963 970 (Pubitemid 32523334)
11. S. Wenzel, D. Wilbraham, R. Fuller, E.B. Getz, and M. Longphre Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Lancet 370 2007 1422 1431 (Pubitemid 47576168)
12. S.K. Saha, M.A. Berry, D. Parker, S. Siddiqui, A. Morgan, and R. May Increased sputum and bronchial biopsy IL-13 expression in severe asthma J Allergy Clin Immunol 121 2008 685 691 (Pubitemid 351323866)
13. C.E. Brightling, S. Saha, and F. Hollins Interleukin-13: prospects for new treatments Clin Exp Allergy 40 2010 42 49
14. D. Singh, B. Kane, N.A. Molfino, R. Faggioni, L. Roskos, and A. Woodcock A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma BMC Pulm Med 10 2010 3
15. G.M. Gauvreau, L.P. Boulet, D.W. Cockcroft, J.M. Fitzgerald, C. Carlsten, and B.E. Davis The effects of IL-13 blockade on allergen-induced airway responses in mild atopic asthma Am J Respir Crit Care Med 183 2010 1007 1014
16. B.L.K. Chawes, M.J. Edwards, B. Shamji, C. Walker, G.C. Nicholson, and A.J. Tan A novel method for assessing unchallenged levels of mediators in nasal epithelial lining fluid [letter] J Allergy Clin Immunol 125 2010 1387 1389
17. H.H. Kariyawasam, G.C. Nicholson, A.J. Tan, N. Syngal, D. Quinn, and C. Boulton Effects of anti-IL-13 (Novartis QAX576) on inflammatory responses following nasal allergen challenge (NAC) Am J Respir Crit Care Med 179 2009 A3542
18. V.A. Varney, M.R. Jacobson, R.M. Sudderick, D.S. Robinson, A.M. Irani, and L.B. Schwartz Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils Am Rev Respir Dis 146 1992 170 176
19. L. Greiff, U. Pipkorn, U. Alkner, and C.G. Persson The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions Clin Exp Allergy 20 1990 253 259 (Pubitemid 20154970)
20. P.M. O'Byrne Allergen-induced airway inflammation and its therapeutic intervention Allergy Asthma Immunol Res 1 2009 3 9
21. M.J. Leckie, A. ten Brinke, J. Khan, Z. Diamant, B.J. O'Connor, and C.M. Walls Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
22. J.C. Kips, B.J. O'Connor, S.J. Langley, A. Woodcock, H.A. Kerstjens, and D.S. Postma Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study Am J Respir Crit Care Med 167 2003 1655 1659 (Pubitemid 36760679)
23. P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, and L. Brannick A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am J Respir Crit Care Med 176 2007 1062 1071 (Pubitemid 350223751)
24. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
25. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
26. P.T. Flood-Page, A.N. Menzies-Gow, A.B. Kay, and D.S. Robinson Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am J Respir Crit Care Med 167 2003 199 204 (Pubitemid 36076080)
27. E.E. Schadt Molecular networks as sensors and drivers of common human diseases Nature 461 2009 218 223